Adverse health effects of marijuana use

New England Journal of Medicine

Volumn 370, Issue 23, 2014, Pages 2219-2227

  Volkow, Nora D ^a   Baler, Ruben D ^a   Compton, Wilson M ^a   Weiss, Susan R B ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIDIOL; CANNABIS; DRONABINOL; NABILONE; NABIXIMOLS; TETRAHYDROCANNABINOL;

ACADEMIC ACHIEVEMENT; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRAIN DEVELOPMENT; CANCER RISK; CANNABIS ADDICTION; CANNABIS SMOKING; CANNABIS USE; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; CHRONIC BRONCHITIS; CHRONIC PAIN; CROHN DISEASE; DISEASE ASSOCIATION; GLAUCOMA; HEALTH HAZARD; HUMAN; INFLAMMATORY BOWEL DISEASE; LUNG CANCER; MENTAL DISEASE; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; RELAPSE; REVIEW; RHEUMATOID ARTHRITIS; SEIZURE; SLEEP DISORDER; SPASTICITY; TRAFFIC ACCIDENT; ULCERATIVE COLITIS; WASTING SYNDROME; WITHDRAWAL SYNDROME;

ACCIDENTS, TRAFFIC; ADOLESCENT; ADULT; AGE FACTORS; BRAIN; CANNABINOIDS; CANNABIS; DRONABINOL; HUMANS; LUNG DISEASES; MARIJUANA ABUSE; MARIJUANA SMOKING; UNITED STATES;

EID: 84901752375     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMra1402309     Document Type: Review

References (77)

1. Center for Behavioral Health Statistics and Quality. National survey on drug use and health. Rockville, MD: Substance Abuse & Mental Health Services Administration, 2013.
2. Fergusson DM, Boden JM. Cannabis use and later life outcomes. Addiction 2008;103:969-76. (Pubitemid 351703484)
3. Lopez-Quintero C, Pérez de los Cobos J, Hasin DS, et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC). Drug Alcohol Depend 2011;115:120-30.
4. Hall W, Degenhardt L. Adverse health effects of non-medical cannabis use. Lancet 2009;374:1383-91.
5. Gorelick DA, Levin KH, Copersino ML, et al. Diagnostic criteria for cannabis withdrawal syndrome. Drug Alcohol Depend 2012;123:141-7.
6. Mechoulam R, Parker LA. The endocannabinoid system and the brain. Annu Rev Psychol 2013;64:21-47.
7. Hall W, Degenhardt L. Prevalence and correlates of cannabis use in developed and developing countries. Curr Opin Psychiatry 2007;20:393-7. (Pubitemid 46889667)
8. Chen CY, Storr CL, Anthony JC. Early-onset drug use and risk for drug dependence problems. Addict Behav 2009;34:319-22.
9. Gogtay N, Giedd JN, Lusk L, et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci U S A 2004;101:8174-9. (Pubitemid 38698073)
10. Dinieri JA, Hurd YL. Rat models of prenatal and adolescent cannabis exposure. Methods Mol Biol 2012;829:231-42.
11. Tortoriello G, Morris CV, Alpar A, et al. Miswiring the brain: Δ9-tetrahydrocannabinol disrupts cortical development by inducing an SCG10/stathmin-2 degradation pathway. EMBO J 2014;33:668-85.
12. Zalesky A, Solowij N, Yücel M, et al. Effect of long-term cannabis use on axonal fibre connectivity. Brain 2012;135:2245-55.
13. Filbey F, Yezhuvath U. Functional connectivity in inhibitory control networks and severity of cannabis use disorder. Am J Drug Alcohol Abuse 2013;39:382-91.
14. Batalla A, Bhattacharyya S, Yücel M, et al. Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings. PLoS One 2013;8(2):e55821.
15. Hirvonen J, Goodwin RS, Li C-T, et al. Reversible and regionally selective downregulation of brain cannabinoid CB1 receptors in chronic daily cannabis smokers. Mol Psychiatry 2012;17:642-9.
16. Meier MH, Caspi A, Ambler A, et al. Persistent cannabis users show neuropsychological decline from childhood to mid-life. Proc Natl Acad Sci U S A 2012;109(40):E2657-E2564.
17. Gaffuri AL, Ladarre D, Lenkei Z. Type-1 cannabinoid receptor signaling in neuronal development. Pharmacology 2012;90:19-39.
18. Pistis M, Perra S, Pillolla G, Melis M, Muntoni AL, Gessa GL. Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons. Biol Psychiatry 2004;56:86-94. (Pubitemid 38849412)
19. DiNieri JA, Wang X, Szutorisz H, et al. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry 2011;70:763-9.
20. Agrawal A, Neale MC, Prescott CA, Kendler KS. A twin study of early cannabis use and subsequent use and abuse/dependence of other illicit drugs. Psychol Med 2004;34:1227-37. (Pubitemid 39517153)
21. Panlilio LV, Zanettini C, Barnes C, Solinas M, Goldberg SR. Prior exposure to THC increases the addictive effects of nicotine in rats. Neuropsychopharmacology 2013;38:1198-208.
22. Levine A, Huang Y, Drisaldi B, et al. Molecular mechanism for a gateway drug: epigenetic changes initiated by nicotine prime gene expression by cocaine. Sci Transl Med 2011;3:107ra109.
23. Patton GC, Coffey C, Carlin JB, Degenhardt L, Lynskey M, Hall W. Cannabis use and mental health in young people: cohort study. BMJ 2002;325:1195-8. (Pubitemid 35398781)
24. Caspi A, Moffitt TE, Cannon M, et al. Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction. Biol Psychiatry 2005;57:1117-27. (Pubitemid 40615773)
25. Di Forti M, Sallis H, Allegri F, et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophr Bull 2014 March 19 (Epub ahead of print).
26. Johnston LD, O'Malley PM, Miech RA, et al. Monitoring the Future: national survey results on drug use, 1975-2013 - overview, key findings on adolescent drug use. Ann Arbor: Institute for Social Research, University of Michigan, 2014 (http://monitoringthefuture.org/pubs/monographs/mtf-overview2013. pdf).
27. Bray JW, Zarkin GA, Ringwalt C, Qi J. The relationship between marijuana initiation and dropping out of high school. Health Econ 2000;9:9-18. (Pubitemid 30079622)
28. Crean RD, Crane NA, Mason BJ. An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions. J Addict Med 2011;5:1-8.
29. Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. Addiction 2000;95:1621-30.
30. Macleod J, Oakes R, Copello A, et al. Psychological and social sequelae of cannabis and other illicit drug use by young people: a systematic review of longitudinal, general population studies. Lancet 2004;363:1579-88. (Pubitemid 38625660)
31. Solowij N, Stephens RS, Roffman RA, et al. Cognitive functioning of long-term heavy cannabis users seeking treatment. JAMA 2002;287:1123-31. [Erratum, JAMA 2002;287:1651.] (Pubitemid 34252081)
32. Schweinsburg AD, Brown SA, Tapert SF. The influence of marijuana use on neurocognitive functioning in adolescents. Curr Drug Abuse Rev 2008;1:99-111.
33. Verweij KJ, Huizink AC, Agrawal A, Martin NG, Lynskey MT. Is the relationship between early-onset cannabis use and educational attainment causal or due to common liability? Drug Alcohol Depend 2013;133:580-6.
34. Brook JS, Lee JY, Finch SJ, Seltzer N, Brook DW. Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abus 2013;34:298-305.
35. Brady JE, Li G. Trends in alcohol and other drugs detected in fatally injured drivers in the United States, 1999-2010. Am J Epidemiol 2014;179:692-9.
36. Lenné MG, Dietze PM, Triggs TJ, Walmsley S, Murphy B, Redman JR. The effects of cannabis and alcohol on simulated arterial driving: influences of driving experience and task demand. Accid Anal Prev 2010;42:859-66.
37. Hartman RL, Huestis MA. Cannabis effects on driving skills. Clin Chem 2013;59:478-92.
38. Ramaekers JG, Berghaus G, van Laar M, Drummer OH. Dose related risk of motor vehicle crashes after cannabis use. Drug Alcohol Depend 2004;73:109-19. (Pubitemid 38068347)
39. Peck RC, Gebers MA, Voas RB, Romano E. The relationship between blood alcohol concentration (BAC), age, and crash risk. J Safety Res 2008;39:311-9.
40. Hashibe M, Morgenstern H, Cui Y, et al. Marijuana use and the risk of lung and upper aerodigestive tract cancers: results of a population-based case-control study. Cancer Epidemiol Biomarkers Prev 2006;15:1829-34. (Pubitemid 44664256)
41. Callaghan RC, Allebeck P, Sidorchuk A. Marijuana use and risk of lung cancer: a 40-year cohort study. Cancer Causes Control 2013;24:1811-20.
42. Tashkin DP. Effects of marijuana smoking on the lung. Ann Am Thorac Soc 2013;10:239-47.
43. Pletcher MJ, Vittinghoff E, Kalhan R, et al. Association between marijuana exposure and pulmonary function over 20 years. JAMA 2012;307:173-81.
44. Owen KP, Sutter ME, Albertson TE. Marijuana: respiratory tract effects. Clin Rev Allergy Immunol 2014;46:65-81.
45. Thomas G, Kloner RA, Rezkalla S. Adverse cardiovascular, cerebrovascular, and peripheral vascular effects of marijuana inhalation: what cardiologists need to know. Am J Cardiol 2014;113:187-90.
46. Stanley C, O'Sullivan SE. Vascular targets for cannabinoids: animal and human studies. Br J Pharmacol 2014;171:1361-78.
47. Rezkalla SH, Sharma P, Kloner RA. Coronary no-flow and ventricular tachycardia associated with habitual marijuana use. Ann Emerg Med 2003;42:365-9. (Pubitemid 37052011)
48. Brown HL, Graves CR. Smoking and marijuana use in pregnancy. Clin Obstet Gynecol 2013;56:107-13.
49. Jutras-Aswad D, DiNieri JA, Harkany T, Hurd YL. Neurobiological consequences of maternal cannabis on human fetal development and its neuropsychiatric outcome. Eur Arch Psychiatry Clin Neurosci 2009;259:395-412.
50. ElSohly MA. Potency Monitoring Program quarterly report no.123 - reporting period: 09/16/2013-12/15/2013. Oxford: University of Mississippi, National Center for Natural Products Research, 2014.
51. Drug Abuse Warning Network, 2011: national estimates of drug-related emergency department visits. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2011 (http://www.samhsa.gov/data/2k13/DAWN2k11ED/ DAWN2k11ED.htm).
52. Joy JE, Watson SJ Jr, Benson JA Jr, eds. Marijuana and medicine: assessing the science base. Washington, DC: National Academy Press, 1999.
53. Merritt JC, Crawford WJ, Alexander PC, Anduze AL, Gelbart SS. Effect of marihuana on intraocular and blood pressure in glaucoma. Ophthalmology 1980;87:222-8. (Pubitemid 10130590)
54. Hepler RS, Frank IR. Marihuana smoking and intraocular pressure. JAMA 1971;217:1392.
55. Chen J, Matias I, Dinh T, et al. Finding of endocannabinoids in human eye tissues: implications for glaucoma. Biochem Biophys Res Commun 2005;330:1062-7.
56. Song ZH, Slowey CA. Involvement of cannabinoid receptors in the intraocular pressure-lowering effects of WIN55212-2. J Pharmacol Exp Ther 2000;292:136-9. (Pubitemid 30026363)
57. Nucci C, Bari M, Spanò A, et al. Potential roles of (endo) cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection. Prog Brain Res 2008;173:451-64.
58. Zuardi AW. Cannabidiol: from an inactive cannabinoid to a drug with wide spectrum of action. Rev Bras Psiquiatr 2008;30:271-80.
59. Sallan SE, Zinberg NE, Frei E III. Anti-emetic effect of delta-9-tetrahydrocannabinol in patients receiving cancer chemotherapy. N Engl J Med 1975;293:795-7.
60. Parker LA, Kwiatkowska M, Burton P, Mechoulam R. Effect of cannabinoids on lithium-induced vomiting in the Suncus murinus (house musk shrew). Psychopharmacology (Berl) 2004;171:156-61. (Pubitemid 38134652)
61. D'Souza G, Matson PA, Grady CD, et al. Medicinal and recreational marijuana use among HIV-infected women in the Women's Interagency HIV Study (WIHS) cohort, 1994-2010. J Acquir Immune Defic Syndr 2012;61:618-26.
62. Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database Syst Rev 2013;4:CD005175.
63. Chiou LC, Hu SS, Ho YC. Targeting the cannabinoid system for pain relief? Acta Anaesthesiol Taiwan 2013;51:161-70.
64. Wilsey B, Marcotte T, Tsodikov A, et al. A randomized, placebo-controlled, crossover trial of cannabis cigarettes in neuropathic pain. J Pain 2008;9:506-21.
65. Wallace M, Schulteis G, Atkinson JH, et al. Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers. Anesthesiology 2007;107:785-96. (Pubitemid 351325971)
66. Wilsey B, Marcotte T, Deutsch R, Gouaux B, Sakai S, Donaghe H. Low-dose vaporized cannabis significantly improves neuropathic pain. J Pain 2013;14:136-48.
67. Cooper ZD, Comer SD, Haney M. Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers. Neuropsychopharmacology 2013;38:1984-92.
68. Nagarkatti P, Pandey R, Rieder SA, Hegde VL, Nagarkatti M. Cannabinoids as novel anti-inflammatory drugs. Future Med Chem 2009;1:1333-49.
69. Esposito G, Filippis DD, Cirillo C, et al. Cannabidiol in inflammatory bowel diseases: a brief overview. Phytother Res 2013;5:633-6.
70. Collin C, Davies P, Mutiboko IK, Ratcliffe S. Randomized controlled trial of cannabis-based medicine in spasticity caused by multiple sclerosis. Eur J 2007;14:290-6. (Pubitemid 46384865)
71. Centonze D, Mori F, Koch G, et al. Lack of effect of cannabis-based treatment on clinical and laboratory measures in multiple sclerosis. Neurol Sci 2009;30:531-4.
72. Porter BE, Jacobson C. Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy. Epilepsy Behav 2013;29:574-7.
73. Kogan NM, Mechoulam R. Cannabinoids in health and disease. Dialogues Clin Neurosci 2007;9:413-30. (Pubitemid 351187565)
74. Hill TD, Cascio MG, Romano B, et al. Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism. Br J Pharmacol 2013;170:679-92.
75. Cristiani SA, Pukay-Martin ND, Bornstein RA. Marijuana use and cognitive function in HIV-infected people. J Neuropsychiatry Clin Neurosci 2004;16:330-5. (Pubitemid 39244559)
76. Niedbala S, Kardos K, Salamone S, Fritch D, Bronsgeest M, Cone EJ. Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol 2004;28:546-52. (Pubitemid 39314852)
77. Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 2012;379:55-70.